One-year clinical outcome of PreserFlo MicroShunt implantation versus trabeculectomy in patients with secondary open-angle glaucoma
Open Access
- 19 February 2026
- journal article
- research article
- Published by Elsevier in Canadian Journal of Ophthalmology
- Vol. 61 (3) , 601-612
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Surgical Outcomes in Uveitic Glaucoma: Long-Term Evaluation of Trabeculectomy, Non-Penetrating Deep Sclerectomy, Ex-PRESS Shunt and Ahmed Glaucoma Valve. A 3-Year Follow-Up StudyOcular Immunology and Inflammation, 2024
- Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt ImplantationAmerican Journal of Ophthalmology, 2023
- Preserflo microshunt implant for the treatment of refractory uveitic glaucoma: 36-month outcomesEye, 2022
- Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United KingdomOphthalmology Glaucoma, 2022
- Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative GlaucomaOphthalmology Glaucoma, 2022
- Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin CAmerican Journal of Ophthalmology, 2020
- The REDCap consortium: Building an international community of software platform partnersJournal of Biomedical Informatics, 2019
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucomaOphthalmology, 2000
- TrabeculectomyAmerican Journal of Ophthalmology, 1968